Effect of Skanlab Regarding Knee Arthrosis

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02649296

Enrollment

Registered

2016-01-07

Start date

2015-10-31

Completion date

2016-12-31

Last updated

2016-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthrosis

Brief summary

The purpose is to find out the effect of Skanlab at knee arthrosis.

Detailed description

The patients diagnosed with knee arthrosis will be treated With Skanlab twice a week for four weeks.

Interventions

OTHERSkanlab bodywave

The intervention will be done twice a week

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

45 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* knee arthrosis in one or both legs

Exclusion criteria

* Pacemaker * infusion pump * cancer * diabetes * pregnancy * blood clots * bacteriological inflammation * reduced sensitivity in the treatment area.

Design outcomes

Primary

Measure	Time frame	Description
Knee injury and Osteoarthritis Outcome Score (KOOS)	15 months	changes in pain

Countries

Norway

Contacts

Primary ContactHilde Sylliaas, Ass prof

hilde.sylliaas@hioa.no

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026